NCT00106639 - A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Kidney Transplantation

Interventions

DRUG

CP-690,550

15 mg twice daily

DRUG

CP-690,550

30 mg twice daily

DRUG

tacrolimus

dose adjusted according to level

Trial Locations (20)

10021

Pfizer Investigational Site, New York

10029

Pfizer Investigational Site, New York

23298

Pfizer Investigational Site, Richmond

53226

Pfizer Investigational Site, Milwaukee

60611

Pfizer Investigational Site, Chicago

63110

Pfizer Investigational Site, St Louis

70112

Pfizer Investigational Site, New Orleans

75204

Pfizer Investigational Site, Dallas

75246

Pfizer Investigational Site, Dallas

80262

Pfizer Investigational Site, Denver

90057

Pfizer Investigational Site, Los Angeles

92123

Pfizer Investigational Site, San Diego

92356

Pfizer Investigational Site, Los Angeles

94115

Pfizer Investigational Site, San Francisco

94304

Pfizer Investigational Site, Palo Alto

94305

Pfizer Investigational Site, Stanford

97210

Pfizer Investigational Site, Portland

94143-0780

Pfizer Investigational Site, San Francisco

63110-1092

Pfizer Investigational Site, St Louis

07039

Pfizer Investigational Site, Livingston